Thanks for posting. Canary Capital was a very early supporter of IHL (under 10 cents) and they know the company better than most. I remember their due diligence before buying a position was exhaustive and they have access to some very clever people.
These comments confirm exactly what many have been trying to say, the results are extremely positive and the opportunity is substantial.
“Canary Capital believes that the current price represents compelling value for a company which currently has seven clinical programs for the development of a new class of medicines to treat conditions with an unmet need (conditions for which there is currently no effective treatment option) and huge market potential if trials are successful. Incannex is clearly a world leader in developing cannabinoid combination medicines and we believe that it is only a matter of time before the market values the company at its true worth.”
IHL Price at posting:
50.5¢ Sentiment: Buy Disclosure: Held
